Before every use, hold the vial up to a light and visually inspect the contents
Stakeholders Interviewed Primary interviews for this study involved: Manufacturers and suppliers in the market value chain Distributors, channel partners, and integrators End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market) Industry experts, technology specialists, consultants, and regulatory professionals Senior executives (CEOs, CTOs, VPs, Directors) and product managers Interview Process Interviews were conducted via: Structured and semi-structured questionnaires Telephonic and video interactions Email correspondences Expert consultation sessions Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation
40 :
The clinical escalation protocol from the Phase 2 NEJM trial established a specific titration schedule that increases the dose every four weeks, starting low and building to a target maintenance dose
A $100 deposit is required at the time of booking
What is the typical BPC-157 dosage for healing